Adrenoleukodystrophy or Adrenomyeloneuropathy

Adrenoleukodystrophy also known as ALD is a genetic disease or an inborn error of metabolism that affects 1 in 18000 people today. This is also known as X linked adrenoleukodystrophy as it is linked to x chromosome. This is a brain disorder that is caused due to the building up of fatty acids which are caused by the enzymes which do not function properly. This results in the destruction of the myelin sheath which is known as a protective sheath that surrounds the neurons in the brain. The destruction of the myelin sheath results in hyperactivity and seizures and also dyslexia. It’s a disorder of peroxisomal fatty acid beta oxidation which results in the accumulation of long fatty acid chains in the body. The adrenal cortex and leydig cells in the testes are also effected. The treatment options for ALD are very limited. Dietary therapy is done by Lorenzo oil. If the defect is spotted in the childhood treatment can be done by stem cell transplant and gene therapy.

  • Dietary therapy
  • Genetics of adernoleukodystrophy
  • Case studies of adrenoleukodystrophy
  • Adrenoleukodystrophy in males and females

Related Conference of Adrenoleukodystrophy or Adrenomyeloneuropathy

February 09-10, 2026

20th International Conference on Endocrinology, Diabetes and Metabolism

Singapore City, Singapore
February 12-13, 2026

5th Global Summit on Physiology and Metabolism of Thyroid

Singapore City, Singapore
February 23-24, 2026

19th International Summit on Diabetes

London, UK
February 25-26, 2026

16th World Congress on Endocrinology and Diabetes

Paris, France
March 09-10, 2026

19th European Diabetes and Endocrinology Congress

London, UK
March 23-24, 2026

25th International Conference on Diabetes, Nutrition, Obesity and Eating Disorders

Rome, Italy
March 23-24, 2026

21st International Conference on Endocrinology and Metabolic Disorders

London, UK
March 26-27, 2026

5th World Congress on Diabetes and Pediatric Endocrinology

London, UK
March 26-27, 2026

7th Global summit on Diabetes and Endocrinology

Amsterdam, Netherlands
April 16-17, 2026

10th International Conference on Diabetes and Cholesterol Metabolism

Tokyo, Japan
April 27-28, 2026

37th International Congress on Prevention of Diabetes and Complications

Vancouver, Canada
April 27-28, 2026

32nd International Conference on Human Metabolic Health- Diabetes, Obesity & Endocrinology

Dubai, UAE
May 14-15, 2026

7th World Summit on Diabetes

Rome, Italy
May 18-19, 2026

57th Annual Congress on Endocrinology and Diabetes Research

Aix-en-Provence, France
May 25-26, 2026

2nd World congress on Endocrinology and Metabolic syndrome

Rome, Italy
May 25-26, 2026

35th International Conference on Clinical Diabetes, Diabetic Medication & Treatment

Zurich, Switzerland
June 08-09, 2026

3rd International Congress on Endocrinology and Complications of Diabetes

Rome, Italy
June 15-16, 2026

35th International Diabetes and Healthcare Conference

Paris, France
June 25-26, 2026

6th European Endocrinology and Diabetes Congress

London, UK
June 25-26, 2026

5th International Summit on Hormonal Disorders

London, UK
June 25-26, 2026

28th World Congress on Diabetes and Endocrine Disorders

London, UK
August 17-18, 2026

6th International Conference on Endocrinology and Diabetes

Toronto, Canada
August 17-18, 2026

4th World congress and Expo on Diabetes

Toronto, Canada
September 23-24, 2026

24th Global Conference on Diabetes, Endocrinology and Primary Healthcare

Paris, France
September 29-30, 2026

22nd World Congress on Endocrinology & Diabetes

Paris, France

Adrenoleukodystrophy or Adrenomyeloneuropathy Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in